Zobrazeno 1 - 5
of 5
pro vyhledávání: '"785"'
Autor:
Jürgen Krauter, Mark Ringhoffer, Arnold Ganser, Brigitte Schlegelberger, Daniela Späth, Marie von Lilienfeld-Toal, David Nachbaur, Hartmut Döhner, Veronica Teleanu, Gerhard Held, Michael Lübbert, Hans Martin, Verena I. Gaidzik, Gudrun Göhring, Sabine Kayser, Patricia Erdmann, Wolfgang Herr, Ulrich Germing, Mathias J. Rummel, Helmut R. Salih, Claus-Henning Köhne, Katharina Götze, H Salwender, Thomas Fischer, Richard F. Schlenk, Peter Paschka, Heinz A. Horst, Konstanze Döhner
Publikováno v:
Blood. 120:785-785
Abstract 785 Background: FLT3 internal tandem duplications (FLT3-ITD) occur in about 25% of acute myeloid leukemia (AML), are associated with cooperating gene mutations (NPM1, DNMT3A), and confer an adverse prognosis. Several studies have indicated t
Autor:
David Marin, Letizia Foroni, Richard E. Clark, Stephen J. O'Brien, Jane F. Apperley, Dragana Milojkovic, John M. Goldman, Corinne Hedgley, Christopher Pocock
Publikováno v:
Blood. 118:785-785
Abstract 785 We assessed the correlation between molecular response at 3 and 6 months of dasatinib 100mg daily treatment and subsequent cytogenetic and molecular responses in 150 newly-diagnosed chronic phase CML patients treated with front line dasa
Autor:
Bayard L. Powell, Denise Williams, Jeffrey H. Lipton, Hanna Jean Khoury, David A. Rizzieri, A. Robert Turner
Publikováno v:
Blood. 114:3295-3295
3295 Poster Board III-1 Background: Nilotinib is a potent and highly selective BCR-ABL kinase inhibitor, approved for the treatment of patients (pts) with Philadelphia chromosome-positive chronic myelogeneous leukemia (Ph+ CML) in chronic phase (CP)
Publikováno v:
Blood. 108:3558-3558
Lenalidomide is an orally active immunomodulatory drug effective in the treatment of multiple myeloma. We evaluated the toxicity and efficacy of MPR combination in a phase I/II study. Patients with newly diagnosed symptomatic multiple myeloma who wer
Publikováno v:
Blood. 104:1776-1776
Inferior vena cava (IVC) filters are an increasingly popular option for patients with thrombosis and the advent of temporary filters may make this procedure an even more desirable alternative. We decided to evaluate how patients with inferior vena ca